Amyloidosis and device therapy: an open debate
- Authors: La Franca E, Corrado E, Inga G, Ciaramitaro G, Novo S, Coppola G.
- Publication year: 2017
- Type: Articolo in rivista (Articolo in rivista)
- Key words: Amyloidosis
- OA Link: http://hdl.handle.net/10447/298618
Abstract
Cardiac involvement represents a critical prognostic factor in amyloidosis, as it represents a leading cause of morbidity and mortality, in primary light chain amyloidosis, in hereditary and also in wild-type transthyretin amyloidosis. A 54-year-old male was admitted to Emergency Room with complaints of dyspnea, palpitations and diaphoresis.